Darling Ingredients Seeks Shareholder Approval for New 2026 Omnibus Incentive Plan with 2.46% Potential Dilution
Summary
Darling Ingredients filed its definitive proxy statement, seeking shareholder approval for a new equity incentive plan that could result in approximately 2.46% dilution, alongside routine governance matters.
Key Events
-
New Equity Incentive Plan Proposed
Shareholders will vote on the 2026 Omnibus Incentive Plan, authorizing 3.9 million new shares for equity awards, representing a potential dilution of approximately 2.46% of current outstanding shares.
-
Board Refreshment
Robert Aspell was appointed to the Board in February 2026, and Lead Director Gary W. Mize will retire at the upcoming Annual Meeting, continuing the company's commitment to board refreshment.
-
Strong Governance Features
The proposed incentive plan includes provisions such as no repricing of underwater options and no dividend payouts on unearned awards, reflecting robust corporate governance.
-
Positive 2025 Financial Highlights
The company reported a net income of $62.8 million and combined adjusted EBITDA of $1.03 billion for fiscal year 2025, alongside a reduction in its bank leverage ratio to 2.90X.
Analysis
The definitive proxy statement outlines proposals for the upcoming annual meeting, including the election of directors, auditor ratification, and an advisory vote on executive compensation. The most significant proposal is the approval of the 2026 Omnibus Incentive Plan, which would authorize 3.9 million new shares for equity awards. This represents a potential dilution of approximately 2.46% of current outstanding shares. While dilutive, the plan incorporates strong governance features such as no repricing of options and no dividend payouts on unearned awards. The filing also highlights positive 2025 financial performance and ongoing board refreshment.
At the time of this filing, DAR was trading at $56.80 on NYSE in the Manufacturing sector, with a market capitalization of approximately $9B. The 52-week trading range was $26.00 to $57.96. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.